hotspot -WSS

hotspot

author：explore 2025-09-30 21:57:43 - browse：52252

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Key House Republican on health care plans exit from Congress

WSS

Community Health Systems hospitals under DOJ investigation

With competition flaring, obesity drug hits goal in liver disease study

To avoid data mishandling cases, universities eye AI and other tools

R1 RCM gets $5.8 billion buyout offer from private equity firm

NIH study of ME/CFS points to clear biological hallmarks

Medicare Advantage proposed rates disappoint insurers

entertainment

hotspot

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Industry veterans launch new biotech VC with $310M

Medical leaders decry Supreme Court decision on affirmative action

Why palliative psychiatry is worth discussing

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Sports medicine is finally prioritizing gender equality

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Trump demands the U.S. pay no more for drugs than other countries … again

He's a Nobel laureate. Critics say he was misleading on Covid

Wikipedia

R1 RCM gets $5.8 billion buyout offer from private equity firm

The dental labor crisis is a moment of opportunity

Robert F. Kennedy is pitching centrism on health, even on abortion

How digital tools helped lower hypertension in marginalized patients

R1 RCM gets $5.8 billion buyout offer from private equity firm

KalVista pill reduced swelling 'attacks' caused by genetic disease

entertainment

hotspot

focus

focus